Show simple item record

dc.contributor.authorPemán, Javier
dc.contributor.authorZaragoza, Rafael
dc.contributor.authorQuindós Andrés, Guillermo
dc.contributor.authorAlkorta, Miriam
dc.contributor.authorCuétara, María S.
dc.contributor.authorCamarena, Juan J.
dc.contributor.authorRamírez, Paula
dc.contributor.authorGiménez, María J.
dc.contributor.authorMartín Mazuelos, Estrella
dc.contributor.authorLinares Sicilia, María J.
dc.contributor.authorPontón, José
dc.contributor.authorCandida albicans Germ Tube Antibody Detection in Critically Ill Patients Study Group
dc.date.accessioned2014-02-20T19:10:29Z
dc.date.available2014-02-20T19:10:29Z
dc.date.issued2011-03
dc.identifier.citationBMC Infectious Diseases 11 : (2011) // Article n. 60es
dc.identifier.issn1471-2334
dc.identifier.urihttp://hdl.handle.net/10810/11597
dc.description.abstractBackground: Poor outcomes of invasive candidiasis (IC) are associated with the difficulty in establishing the microbiological diagnosis at an early stage. New scores and laboratory tests have been developed in order to make an early therapeutic intervention in an attempt to reduce the high mortality associated with invasive fungal infections. Candida albicans IFA IgG has been recently commercialized for germ tube antibody detection (CAGTA). This test provides a rapid and simple diagnosis of IC (84.4% sensitivity and 94.7% specificity). The aim of this study is to identify the patients who could be benefited by the use of CAGTA test in critical care setting. Methods: A prospective, cohort, observational multicentre study was carried out in six medical/surgical Intensive care units (ICU) of tertiary-care Spanish hospitals. Candida albicans Germ Tube Antibody test was performed twice a week if predetermined risk factors were present, and serologically demonstrated candidiasis was considered if the testing serum dilution was >= 1: 160 in at least one sample and no other microbiological evidence of invasive candidiasis was found. Results: Fifty-three critically ill non-neutropenic patients (37.7% post surgery) were included. Twenty-two patients (41.5%) had CAGTA-positive results, none of them with positive blood culture for Candida. Neither corrected colonization index nor antifungal treatment had influence on CAGTA results. This finding could corroborate that the CAGTA may be an important biomarker to distinguish between colonization and infection in these patients. The presence of acute renal failure at the beginning of the study was more frequent in CAGTA-negative patients. Previous surgery was statistically more frequent in CAGTA-positive patients. Conclusions: This study identified previous surgery as the principal clinical factor associated with CAGTA-positive results and emphasises the utility of this promising technique, which was not influenced by high Candida colonization or antifungal treatment. Our results suggest that detection of CAGTA may be important for the diagnosis of invasive candidiasis in surgical patients admitted in ICU.es
dc.description.sponsorshipThis study has been supported by a Pfizer research grantes
dc.language.isoenges
dc.publisherBioMed Centrales
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectcritically ill patienses
dc.subjectinvasive candidiasises
dc.subjectamphotericin-Bes
dc.subjectsystemic candidiasises
dc.subjectantifungal therapyes
dc.subjectspecies infectionses
dc.subjectfungal infectionses
dc.subjectsurgical patientses
dc.subjectearly diagnosises
dc.subjectblood cultureses
dc.titleClinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patientses
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2011 Pemán et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.es
dc.relation.publisherversionhttp://www.biomedcentral.com/1471-2334/11/60es
dc.identifier.doi10.1186/1471-2334-11-60
dc.departamentoesInmunología, microbiología y parasitologíaes_ES
dc.departamentoeuImmunologia, mikrobiologia eta parasitologiaes_ES
dc.subject.categoriaINFECTIOUS DISEASES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record